Vaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than Apoptosis

Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins that modulate the host response to infection. Two such proteins, B14 and A52, act inside infected cells to inhibit activation of NF-κB, thereby blocking the production of pro-inflammatory cytokines. We have solved the crystal s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Graham, Stephen C., Bahar, Mohammad W., Cooray, Samantha, Chen, Ron A.-J., Whalen, Daniel M., Abrescia, Nicola G. A., Alderton, David, Owens, Raymond J., Stuart, David I., Smith, Geoffrey L., Grimes, Jonathan M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2008
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494871/
https://ncbi.nlm.nih.gov/pubmed/18704168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1000128
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak